Over the last eight months, Proximo Medical has grown its business by partnering with technologies in the peripheral space, including EMBA, PMT Partners, Walk Vascular, PEDRA Tech and BIOTRONIK. Each device holds hope and promise for workflow efficiency in the medical suite and, most importantly, better patient outcomes. Our goal is to successfully commercialize partner innovations, accelerating market entry and clinical adoption.
Proximo Medical is pleased to now bring that expertise to the coronary space.
Our recent partnership with CeloNova Biosciences, Inc., a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F (PzF) nanocoating technology, including the COBRA PzF NCS a non drug-eluting, nanocoated coronary stent. This partnership provides Proximo Medical the opportunity to apply its successful approach to marketing and sales stamina to the coronary field.
Do you have a proven track record in coronary sales? Are you passionate about medical device innovation and disruptive technologies? Are you ready for a change in 2020?
Click HERE to be considered for the team.